Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jo Lambert

Showing results (101-110 of 134) with videos related to

Pageof 14
Sort By:
European Journal of Cancer (Oxford, England : 1990)|October 29, 2011
Indoleamine 2,3-dioxygenase, a new prognostic marker in sentinel lymph nodes of melanoma patientsReinhart Speeckaert, Karim Vermaelen, Nanja van Geel, et al.
JAMA Dermatology|March 26, 2015
Developing a Therapeutic Range of Adalimumab Serum Concentrations in Management of Psoriasis: A Step Toward Personalized TreatmentStef P Menting, Emma Coussens, Mieke F Pouw, et al.
Journal of the American Academy of Dermatology|December 20, 2023
Deucravacitinib, a selective, allosteric tyrosine kinase 2 inhibitor, in scalp psoriasis: A subset analysis of two phase 3 randomized trials in plaque psoriasisAndrew Blauvelt, Phoebe Rich, Howard Sofen, et al.
BMJ Open|February 15, 2023
Patient-reported well-being in value-based care using tildrakizumab in a real-world setting: protocol of a multinational, phase IV, 1-cohort prospective observational study (the POSITIVE study)Matthias Augustin, Rachel Sommer, Esteban Daudén, et al.
The Journal of Experimental Medicine|September 17, 2008
Human squamous cell carcinomas evade the immune response by down-regulation of vascular E-selectin and recruitment of regulatory T cellsRachael A Clark, Susan J Huang, George F Murphy, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 9, 2023
Freedom from disease in plaque psoriasis: Comparing the perceived importance of voting round 2 statements from a Delphi consensus of patients, physicians and nursesIlse van Ee, Elfie Deprez, Alexander Egeberg, et al.
Journal of Comparative Effectiveness Research|February 28, 2023
A plain language summary of what freedom from disease means to people with psoriasis according to doctors, nurses, and people with psoriasisIlse van Ee, Elfie Deprez, Alexander Egeberg, et al.
The Journal of Investigative Dermatology|October 12, 2016
Elevated ΔNp63α Levels Facilitate Epidermal and Biliary Oncogenic TransformationMichael Devos, Barbara Gilbert, Geertrui Denecker, et al.
Journal of the National Cancer Institute|May 21, 2010
Effect of the secretory small GTPase Rab27B on breast cancer growth, invasion, and metastasisAn Hendrix, Dawn Maynard, Patrick Pauwels, et al.
The Journal of Investigative Dermatology|November 22, 2023
Quantifying the Effect of Methotrexate on Adalimumab Response in Psoriasis by Pharmacokinetic-Pharmacodynamic ModelingAstrid van Huizen, Paul Bank, Gayle van der Kraaij, et al.
Pageof 14

Showing results (101-110 of 134) with videos related to

Sort By:
Pageof 14
European Journal of Cancer (Oxford, England : 1990)|October 29, 2011
Indoleamine 2,3-dioxygenase, a new prognostic marker in sentinel lymph nodes of melanoma patientsReinhart Speeckaert, Karim Vermaelen, Nanja van Geel, et al.
JAMA Dermatology|March 26, 2015
Developing a Therapeutic Range of Adalimumab Serum Concentrations in Management of Psoriasis: A Step Toward Personalized TreatmentStef P Menting, Emma Coussens, Mieke F Pouw, et al.
Journal of the American Academy of Dermatology|December 20, 2023
Deucravacitinib, a selective, allosteric tyrosine kinase 2 inhibitor, in scalp psoriasis: A subset analysis of two phase 3 randomized trials in plaque psoriasisAndrew Blauvelt, Phoebe Rich, Howard Sofen, et al.
BMJ Open|February 15, 2023
Patient-reported well-being in value-based care using tildrakizumab in a real-world setting: protocol of a multinational, phase IV, 1-cohort prospective observational study (the POSITIVE study)Matthias Augustin, Rachel Sommer, Esteban Daudén, et al.
The Journal of Experimental Medicine|September 17, 2008
Human squamous cell carcinomas evade the immune response by down-regulation of vascular E-selectin and recruitment of regulatory T cellsRachael A Clark, Susan J Huang, George F Murphy, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 9, 2023
Freedom from disease in plaque psoriasis: Comparing the perceived importance of voting round 2 statements from a Delphi consensus of patients, physicians and nursesIlse van Ee, Elfie Deprez, Alexander Egeberg, et al.
Journal of Comparative Effectiveness Research|February 28, 2023
A plain language summary of what freedom from disease means to people with psoriasis according to doctors, nurses, and people with psoriasisIlse van Ee, Elfie Deprez, Alexander Egeberg, et al.
The Journal of Investigative Dermatology|October 12, 2016
Elevated ΔNp63α Levels Facilitate Epidermal and Biliary Oncogenic TransformationMichael Devos, Barbara Gilbert, Geertrui Denecker, et al.
Journal of the National Cancer Institute|May 21, 2010
Effect of the secretory small GTPase Rab27B on breast cancer growth, invasion, and metastasisAn Hendrix, Dawn Maynard, Patrick Pauwels, et al.
The Journal of Investigative Dermatology|November 22, 2023
Quantifying the Effect of Methotrexate on Adalimumab Response in Psoriasis by Pharmacokinetic-Pharmacodynamic ModelingAstrid van Huizen, Paul Bank, Gayle van der Kraaij, et al.
Pageof 14